2487 — Cutia Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- HK$2.38bn
- HK$1.95bn
- CNY279.62m
Annual balance sheet for Cutia Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 1,378 | 1,077 | 1,273 | 876 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.499 | 4.12 | 77 | 105 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1,402 | 1,145 | 1,416 | 1,087 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 62.9 | 240 | 231 | 228 |
| Net Intangible Assets | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 1,495 | 1,447 | 1,707 | 1,393 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 19.3 | 77.4 | 255 | 323 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 2,285 | 2,693 | 358 | 419 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Total Equity | -791 | -1,246 | 1,349 | 975 |
| Total Liabilities & Shareholders' Equity | 1,495 | 1,447 | 1,707 | 1,393 |
| Total Common Shares Outstanding |